KURA ONCOLOGY, INC. Increase (Decrease) in Accounts Receivable, Related Parties
KURA ONCOLOGY, INC. (KURA) reported Increase (Decrease) in Accounts Receivable, Related Parties of $1.00 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties · last filed 2020-05-04
- KURA ONCOLOGY, INC. increase (decrease) in accounts receivable, related parties for the quarter ending 2020-03-31 was $1.00K.
- KURA ONCOLOGY, INC. increase (decrease) in accounts receivable, related parties for the quarter ending 2019-12-31 was -$17.00K.
- KURA ONCOLOGY, INC. increase (decrease) in accounts receivable, related parties for the quarter ending 2019-09-30 was -$64.00K, a 3300.00% decline year-over-year.
- KURA ONCOLOGY, INC. increase (decrease) in accounts receivable, related parties for the quarter ending 2019-06-30 was -$84.00K.
- KURA ONCOLOGY, INC. increase (decrease) in accounts receivable, related parties for fiscal 2019 was -$210.00K, a 2725.00% decline from fiscal 2018.
- KURA ONCOLOGY, INC. increase (decrease) in accounts receivable, related parties for fiscal 2018 was $8.00K.
- KURA ONCOLOGY, INC. increase (decrease) in accounts receivable, related parties for fiscal 2017 was -$79.00K.
- KURA ONCOLOGY, INC. increase (decrease) in accounts receivable, related parties for fiscal 2016 was -$135.00K, a 133.75% decline from fiscal 2015.
| Period end | Increase (Decrease) in Accounts Receivable, Related Parties 3 month | Increase (Decrease) in Accounts Receivable, Related Parties 4 month | Increase (Decrease) in Accounts Receivable, Related Parties 6 month | Increase (Decrease) in Accounts Receivable, Related Parties 9 month | Increase (Decrease) in Accounts Receivable, Related Parties 12 month |
|---|---|---|---|---|---|
| 2020-03-31 | $1.00K 10-Q · filed 2020-05-04 | -$16.00K derived: sum of 2 quarters · filed 2020-05-04 | -$80.00K derived: sum of 3 quarters · filed 2020-05-04 | -$164.00K derived: sum of 4 quarters · filed 2020-05-04 | |
| 2019-12-31 | -$17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$81.00K derived: sum of 2 quarters · filed 2020-02-25 | -$165.00K derived: sum of 3 quarters · filed 2020-02-25 | -$210.00K 10-K · filed 2020-02-25 | |
| 2019-09-30 | -$64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$148.00K derived: sum of 2 quarters · filed 2019-11-05 | -$193.00K 10-Q · filed 2019-11-05 | -$201.00K derived: sum of 4 quarters · filed 2020-05-04 | |
| 2019-06-30 | -$84.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$129.00K 10-Q · filed 2019-08-01 | -$137.00K derived: sum of 3 quarters · filed 2020-05-04 | -$135.00K derived: sum of 4 quarters · filed 2020-05-04 | |
| 2019-03-31 | -$45.00K 10-Q · filed 2020-05-04 | -$53.00K derived: sum of 2 quarters · filed 2020-05-04 | -$51.00K derived: sum of 3 quarters · filed 2020-05-04 | -$78.00K derived: sum of 4 quarters · filed 2020-05-04 | |
| 2018-12-31 | -$8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$6.00K derived: sum of 2 quarters · filed 2020-02-25 | -$33.00K derived: sum of 3 quarters · filed 2020-02-25 | $8.00K 10-K · filed 2020-02-25 | |
| 2018-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$25.00K derived: sum of 2 quarters · filed 2019-11-05 | $16.00K 10-Q · filed 2019-11-05 | $23.00K derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-06-30 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $14.00K 10-Q · filed 2019-08-01 | $21.00K derived: sum of 3 quarters · filed 2020-02-25 | -$74.00K derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-03-31 | $41.00K 10-Q · filed 2019-05-07 | $48.00K derived: sum of 2 quarters · filed 2020-02-25 | -$47.00K derived: sum of 3 quarters · filed 2020-02-25 | -$84.00K derived: sum of 4 quarters · filed 2020-02-25 | |
| 2017-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$88.00K derived: sum of 2 quarters · filed 2020-02-25 | -$125.00K derived: sum of 3 quarters · filed 2020-02-25 | -$79.00K 10-K · filed 2020-02-25 | |
| 2017-09-30 | -$95.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | -$132.00K derived: sum of 2 quarters · filed 2018-11-05 | -$86.00K 10-Q · filed 2018-11-05 | -$52.00K derived: sum of 4 quarters · filed 2018-11-05 | |
| 2017-06-30 | -$37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $9.00K 10-Q · filed 2018-08-06 | $43.00K derived: sum of 3 quarters · filed 2018-08-06 | $18.00K derived: sum of 4 quarters · filed 2018-08-06 | |
| 2017-03-31 | $46.00K 10-Q · filed 2018-05-08 | $80.00K derived: sum of 2 quarters · filed 2018-05-08 | $55.00K derived: sum of 3 quarters · filed 2018-05-08 | -$65.00K derived: sum of 4 quarters · filed 2018-05-08 | |
| 2016-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $9.00K derived: sum of 2 quarters · filed 2018-03-12 | -$111.00K derived: sum of 3 quarters · filed 2018-03-12 | -$135.00K 10-K · filed 2018-03-12 | |
| 2016-09-30 | -$25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$145.00K derived: sum of 2 quarters · filed 2017-11-07 | -$169.00K 10-Q · filed 2017-11-07 | -$118.00K derived: sum of 4 quarters · filed 2017-11-07 | |
| 2016-06-30 | -$120.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$144.00K 10-Q · filed 2017-08-07 | -$93.00K derived: sum of 3 quarters · filed 2017-08-07 | -$86.00K derived: sum of 4 quarters · filed 2017-08-07 | |
| 2016-03-31 | -$24.00K 10-Q · filed 2017-05-15 | $27.00K derived: sum of 2 quarters · filed 2017-05-15 | $34.00K derived: sum of 3 quarters · filed 2017-05-15 | $58.00K derived: sum of 4 quarters · filed 2017-05-15 | |
| 2015-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $58.00K derived: sum of 2 quarters · filed 2017-03-14 | $82.00K derived: sum of 3 quarters · filed 2017-03-14 | $400.00K 10-K · filed 2017-03-14 | |
| 2015-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $31.00K derived: sum of 2 quarters · filed 2016-11-07 | $349.00K 10-Q · filed 2016-11-07 | ||
| 2015-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | $342.00K 10-Q · filed 2016-08-10 | |||
| 2015-03-31 | $318.00K 10-Q · filed 2016-05-11 | ||||
| 2014-12-31 | $30.00K 10-K · filed 2016-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |